High-dose rate surface mold brachytherapy in a case of squamous cell carcinoma of lower eyelid: A case report from a rural cancer center of Maharashtra

• Main Authors: Vandana Shailendra Jain, Vidyasagar Kushwah, P Waghmare Chaitali, B Sarje Mukund
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2019-01-01
• Series: Journal of Radiation and Cancer Research
• Subjects: High-dose rate brachytherapy; lower eyelid malignancies; surface mold brachytherapy
• Online Access: http://www.journalrcr.org/article.asp?issn=2588-9273;year=2019;volume=10;issue=2;spage=124;epage=127;aulast=Jain

Squamous cell carcinoma (SCC) of skin is an uncontrolled growth of cells of epithelium commonly seen in males in fifth to sixth decade of life. Risk factors include fair skin, blonde hair, exposure to sunlight (ultraviolet B), immunosuppression, human papillomavirus, and genetics. Surface mold brachytherapy (SMB) is a well-established treatment for early stage head and neck cancers involving accessible sites. It has evolved from the radium era to low-dose rate and now to high-dose rate intensity-modulated interventional brachytherapy. We present a 50-year-old male patient with squamous carcinoma of the left lower eyelid and was operated for the same. Histopathology was well-differentiated SCC with all positive margins. The patient was then treated by SMB and evaluated for toxicity, local control, and survival.